tiprankstipranks
TScan Therapeutics (TCRX)
NASDAQ:TCRX
US Market
TCRX
TScan Therapeutics
RESEARCH TOOLSreports

TScan Therapeutics (TCRX) Cash flow

357 Followers

TScan Therapeutics Cash Flow

TCRX's free cash flow for Q4 2025 was $-32.17M. For the 2025 fiscal year, TCRX's free cash flow was decreased by $-25.08M and operating cash flow was $-32.00M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -135.32M$ -110.82M$ -61.36M$ -66.50M$ -48.68M
Investing Cash Flow
$ 109.37M$ -52.61M$ -60.76M$ -4.22M$ -9.94M
Financing Cash Flow
$ -336.00K$ 208.76M$ 135.44M$ 29.36M$ 189.67M
End Cash Position
$ 157.44M$ 183.72M$ 138.39M$ 125.06M$ 166.44M
Free Cash Flow
$ -139.73M$ -114.65M$ -64.50M$ -70.73M$ -58.62M
Currency in USD

TScan Therapeutics Cash Flow